Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 3 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis.
Blood Cancer J. 2023 Jan 30;13(1):21. doi: 10.1038/s41408-023-00786-x.
Blood Cancer J. 2023.
PMID: 36710362
Free PMC article.
No abstract available.
CALR mutation burden in essential thrombocythemia and disease outcome.
Guglielmelli P, Szuber N, Gangat N, Capecchi G, Maccari C, Harnois M, Karrar O, Abdelmagid M, Balliu M, Nacca E, Atanasio A, Sestini I, Désilets A, Loscocco GG, Rotunno G, Busque L, Tefferi A, Vannucchi AM.
Guglielmelli P, et al. Among authors: atanasio a.
Blood. 2024 Mar 28;143(13):1310-1314. doi: 10.1182/blood.2023023428.
Blood. 2024.
PMID: 38252902
Item in Clipboard
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience.
Loscocco GG, Gesullo F, Capecchi G, Atanasio A, Maccari C, Mannelli F, Vannucchi AM, Guglielmelli P.
Loscocco GG, et al. Among authors: atanasio a.
Blood Cancer J. 2024 Jan 18;14(1):10. doi: 10.1038/s41408-023-00968-7.
Blood Cancer J. 2024.
PMID: 38238287
Free PMC article.
Item in Clipboard
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis.
Coltro G, Mannelli F, Loscocco GG, Mannarelli C, Rotunno G, Maccari C, Pancani F, Atanasio A, Vannucchi AM, Guglielmelli P.
Coltro G, et al. Among authors: atanasio a.
Blood Cancer J. 2022 Aug 12;12(8):116. doi: 10.1038/s41408-022-00713-6.
Blood Cancer J. 2022.
PMID: 35961958
Free PMC article.
No abstract available.
Item in Clipboard
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study.
Vannucchi AM, Sordi B, Morettini A, Nozzoli C, Poggesi L, Pieralli F, Bartoloni A, Atanasio A, Miselli F, Paoli C, Loscocco GG, Fanelli A, Para O, Berni A, Tassinari I, Zammarchi L, Maggi L, Mazzoni A, Scotti V, Falchetti G, Malandrino D, Luise F, Millotti G, Bencini S, Capone M, Piccinni MP, Annunziato F, Guglielmelli P; RUXO-COVID Study Group.
Vannucchi AM, et al. Among authors: atanasio a.
Leukemia. 2021 Apr;35(4):1121-1133. doi: 10.1038/s41375-020-01018-y. Epub 2020 Aug 19.
Leukemia. 2021.
PMID: 32814839
Free PMC article.
Clinical Trial.
Item in Clipboard
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib.
Coltro G, Capecchi G, Maffioli M, Mannelli F, Mora B, Atanasio A, Iurlo A, Maccari C, Farina M, Nacca E, Caramella M, Signori L, Borella M, Bertù L, Esposito M, Guglielmelli P, Passamonti F, Vannucchi AM.
Coltro G, et al. Among authors: atanasio a.
Haematologica. 2024 May 30. doi: 10.3324/haematol.2024.285098. Online ahead of print.
Haematologica. 2024.
PMID: 38813708
Free article.
Item in Clipboard
Testing for rare types of Hereditary Hemochromatosis. A genetic study of two Italian families affected by early onset iron overload.
Atanasio A, Bernabini S, Consagra A, Giotti I, Carrai V, Pelo E, Vannucchi AM.
Atanasio A, et al.
Int J Lab Hematol. 2023 Oct;45(5):784-787. doi: 10.1111/ijlh.14062. Epub 2023 Mar 22.
Int J Lab Hematol. 2023.
PMID: 36949728
No abstract available.
Item in Clipboard
Cite
Cite